和厚朴酚脂质体的制备及其体外抗肿瘤活性的研究
合集下载
相关主题
- 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
- 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
- 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。
determined by Zetasizer nano ZS and transmission electron microscope (TEM), respectively; DiL fluorescence probe was
used to mark the liposome-HNK and to explore the cellular uptake in a time dependent fashion; the pharmacological
(0.24 ±0.00) and zeta potential was (53.23 ±1.16)mV; when the lipid-drug ratio was 7% , the encapsulation rate
reached the highest, as high as (99.47±0.20)% and had a long-term stability in 4℃ environment; the apoptosis rate of
老年医学与保健 2019 年第 25 卷第 1 期 Geriatr Health Care,2019,Vol.25.No.1
和厚朴酚脂质体的制备及其体外抗肿瘤活性的研究
魏晓 1,杜子秀 2,陆平 1
1.上海交通大学医学院附属第九人民医院老年科,上海 200011;2.上海交通大学药学院,上海 200240
effects of liposomLeabharlann Baidu-HNK on HCCLM3 cells were detected by WST -1 and BD apoptosis kits.
Liposome-HNK
was (112.30±0.78) nm in average particle size with even size distribution, the polydispersity index (PDI) value was
liposome-HNK was significantly higher than that in free-drug group ( <0.05).
The preparation process of
liposome-HNK is simple and feasible, and it has stable physicochemical property, high encapsulation rate and higher
[关键词] 和厚朴酚;脂质体;肝肿瘤;人肝癌高转移细胞
Preparation of Honokiol Liposomes and Their Antitumor Activity in Vitro Wei Xiao1, Du Zixiu2*, Lu Ping1*
*Corresponding author:Du Zixiu, E-mail: zixiudu@sjtu.edu.cn Lu Ping, E-mail: luping.shanghai@163.com
Liposome-HNK with different lipid-drug ratio was prepared by thin film dispersed method (TFDM) and determination of
encapsulation efficiency (EE) was made; the particle size distribution of liposome-HNK and the time stability were
pharmaceutical effect.
honokiol(HNK); liposome; liver neoplasms; highly metastatic human hepatocellular carcinoma cell
我国的原发性肝癌死亡率位居恶性肿瘤第 2 位[1],其治愈率低,转移率高。检出时大多已属中晚
基金项目:国家自然科学基金(81300092) 共同通信作者:杜子秀,电子信箱:zixiudu@sjtu.edu.cn
To prepare the DOTAP/DOPE honokiol liposomes (liposome-HNK) and to explore their
physicochemical property and pharmacodynamics to treat human hepatocellular carcinoma cells lines (HCCLM3).
[摘要] 目的 制备(2,3-二油酰基-丙基)-三甲胺(1,2-dioleoyl-3-trimethylammonium-propane,DOTAP)/二油酰磷 脂酰乙醇胺(dioleoyl phosphoethanolamine, DOPE)包裹和厚朴酚脂质体,并对其理化性质和人肝癌高转移细胞(highly metastatic human hepatocellular carcinoma cell, HCCLM3)的药效学进行研究。方法 利用薄膜分散法制得和厚朴酚脂质 体,对不同药脂比的包封率进行考察;通过纳米粒度仪检测和厚朴酚脂质体的粒径电势分布、时间稳定性;通过生物透 射电镜(transmission electron microscopy, TEM)对其大小和形态学进行观测;用细胞膜红色荧光探针标记和厚朴酚脂质 体,探究HCCLM3细胞对脂质体摄取的时间依赖性;用WST-1和BD凋亡试剂盒检测和厚朴酚脂质体对HCCLM3细胞的 药效作用。结果 和厚朴酚脂质体粒径分布均匀,平均粒径为(112.30±0.78)nm,多分散系数为(0.24±0.00),电势为 (53.23±1.16)mV。药脂比为7%时包封率最高,高达(99.47±0.20)%,并且在4℃环境下可以长期稳定存在。和厚朴酚脂 质体的促凋亡水平明显强于原药,差异有统计学意义( <0.05)。结论 和厚朴酚脂质体制备工艺简单易行,具有稳定 的理化性质和较高的包封率,同时优于和厚朴酚原药的药效作用。